Literature DB >> 9519760

Human peroxisome proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes.

C Vigouroux1, L Fajas, E Khallouf, M Meier, G Gyapay, O Lascols, J Auwerx, J Weissenbach, J Capeau, J Magré.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9519760     DOI： 10.2337/diabetes.47.3.490

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  19 in total

1.  A case of congenital generalized lipodystrophy: metabolic effects of four dietary regimens. Lack of association of CGL with polymorphism in the lamin A/C Gene.

Authors:  R Kazlauskaite; A T Santomauro; J Goldman; K Silver; S Snitker; B A Beamer; C J Yen; A R Shuldiner; B L Wajchenberg
Journal:  Clin Endocrinol (Oxf)       Date:  2001-03       Impact factor: 3.478

Review 2.  Lipoatrophic diabetes and other related syndromes.

Authors:  Elif Arioglu Oral
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

3.  Maternal urinary phthalate metabolites in relation to gestational diabetes and glucose intolerance during pregnancy.

Authors:  Rachel M Shaffer; Kelly K Ferguson; Lianne Sheppard; Tamarra James-Todd; Samantha Butts; Suchitra Chandrasekaran; Shanna H Swan; Emily S Barrett; Ruby Nguyen; Nicole Bush; Thomas F McElrath; Sheela Sathyanarayana
Journal:  Environ Int       Date:  2019-01-07       Impact factor: 9.621

4.  Association between C1431T polymorphism in peroxisome proliferator-activated receptor-γ gene and coronary artery disease in Chinese Han population.

Authors:  Xiang Zhou; Jianchang Chen; Weiting Xu
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

5.  Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer.

Authors:  Ioannis A Voutsadakis
Journal:  World J Gastrointest Oncol       Date:  2010-05-15

Review 6.  PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine.

Authors:  Simona Cataldi; Valerio Costa; Alfredo Ciccodicola; Marianna Aprile
Journal:  Curr Diab Rep       Date:  2021-04-18       Impact factor: 4.810

7.  Catalase and PPARgamma2 genotype and risk of rheumatoid arthritis in Koreans.

Authors:  Ahmed El-Sohemy; Marilyn C Cornelis; Yong-Wook Park; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2005-06-30       Impact factor: 2.631

8.  Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutation.

Authors:  Jean-Marc Guettier; Jean Y Park; Elaine K Cochran; Christine Poitou; Arnaud Basdevant; Muriel Meier; Karine Clément; Jocelyne Magré; Phillip Gorden
Journal:  Clin Endocrinol (Oxf)       Date:  2007-12-10       Impact factor: 3.478

Review 9.  Peroxisome proliferator-activated receptor gamma (PPARgamma) and colorectal carcinogenesis.

Authors:  Ioannis A Voutsadakis
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-21       Impact factor: 4.553

10.  Peroxisome proliferator-activated receptor gamma and regulations by the ubiquitin-proteasome system in pancreatic cancer.

Authors:  Athina Stravodimou; Gianluigi Mazzoccoli; Ioannis A Voutsadakis
Journal:  PPAR Res       Date:  2012-09-19       Impact factor: 4.964
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.